Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of eight programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts. The company trades on NASDAQ exchange. The company headquarter is located in Cambridge, Massachusetts. The company was established in the 2016.

TickerGBIO
Long NameGeneration Bio Co.
Short NameGeneration Bio Co.